Totally implantable venous-access ports: local problems and extravasation injury
S Kurul, P Saip, T Aydin - The lancet oncology, 2002 - thelancet.com
The most important feature of catheter insertion is strict adherence to sterile technique.
Proper positioning of the catheter tip at the junction of the superior vena cava and the right …
Proper positioning of the catheter tip at the junction of the superior vena cava and the right …
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III …
…, K Gyurkovits, E Ulsperger, J Jassem, M Grgic, P Saip… - Lung cancer, 2006 - Elsevier
PURPOSE: The primary objective of this randomized phase III study was to show significant
difference in median time to progression (TTP) in patients with advanced NSCLC treated …
difference in median time to progression (TTP) in patients with advanced NSCLC treated …
[HTML][HTML] MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer
Background Triple-negative breast cancer is estimated to account for 15%–20% of all
patients with breast cancer and is considered as a prognostically unfavorable subset. The …
patients with breast cancer and is considered as a prognostically unfavorable subset. The …
[HTML][HTML] Metaplastic breast carcinoma versus triple-negative breast cancer: survival and response to treatment
A Aydiner, F Sen, M Tambas, R Ciftci, Y Eralp, P Saip… - Medicine, 2015 - journals.lww.com
Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas
regarding incidence, pathogenesis, and prognosis. The purpose of this study was to …
regarding incidence, pathogenesis, and prognosis. The purpose of this study was to …
Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors
OBJECTIVE: To evaluate the clinicopathological prognostic features, factors and outcomes
of chemotherapy in ovarian yolk sac tumours (YST). STUDY DESIGN: We reviewed the …
of chemotherapy in ovarian yolk sac tumours (YST). STUDY DESIGN: We reviewed the …
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters
B Vural, LC Chen, P Saip, YT Chen, Z Ustuner… - Cancer, 2005 - Wiley Online Library
BACKGROUND Expression of neuroectodermal markers is a key feature of small cell lung
carcinoma (SCLC). Although immune responses against a number of these proteins have …
carcinoma (SCLC). Although immune responses against a number of these proteins have …
Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy
…, Y Eralp, EE Akisik, EZ Akisik, P Saip… - Clinical Chemical …, 2008 - degruyter.com
Background: The integrity of circulating cell-free DNA (cf-DNA) in serum or plasma appears
to be of diagnostic and prognostic value in cancer. Here, we investigated the dynamics of …
to be of diagnostic and prognostic value in cancer. Here, we investigated the dynamics of …
New biomarkers in peripheral blood of patients with ovarian cancer: high expression levels of miR-16-5p, miR-17-5p, and miR-638
…, DA Odemis, OS Erdogan, SK Erciyas, P Saip… - Archives of Gynecology …, 2022 - Springer
Objectives Ovarian cancer is one of the most fatal gynecologic malignities. miR-16-5p, miR-
17-5p, and miR-638 genes were found to have been associated with ovarian cancer in …
17-5p, and miR-638 genes were found to have been associated with ovarian cancer in …
[HTML][HTML] Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
…, E Aydin, N Khanmammadov, N Paksoy, P Saip… - Scientific Reports, 2023 - nature.com
The purpose of the study was to assess the prognosis of HER2-positive metastatic breast
cancer patients who received trastuzumab beyond progression and investigate the …
cancer patients who received trastuzumab beyond progression and investigate the …
Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary
OBJECTIVES: The objectives of this study were to evaluate the patients' characteristics and
treatment results for 11 recurrent granulosa cell tumors (GCT) of the ovary. METHODS …
treatment results for 11 recurrent granulosa cell tumors (GCT) of the ovary. METHODS …